Expert Consensus: Weight loss physicians consistently report that properly compounded tirzepatide and semaglutide from FDA-registered facilities produce results equivalent to brand-name medications
doi: 10.3389/fnut.2025.1585922 Received 01 March 2025 Accepted 28 April 2025 Published 16 May 2025 Volume 12 - 2025 Edited by Mark Elisabeth Willems, University of Chichester, United Kingdom Reviewed by Luiz Royes, Federal University of Santa Maria, Brazil Alessandra DAmico, Sapienza University of Rome, Italy Lillian Morton, The University of Auckland, New Zealand Updates Copyright 2025 Wang and Yu
Factors Influencing Popcorn Tolerance Understanding how popcorn is prepared and consumed significantly impacts its digestibility and potential to cause discomfort while on GLP-1 medications
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidemia: results from a Phase 2 trial
doi: 10.1146/annurev-nutr-110420-111710 138
It is FDA-approved to treat both type 2 diabetes and, more recently, obesity
